EANM has joined as co-organiser of the European Multidisciplinary Congress on Urological Cancers (EMUC26), bringing nuclear medicine expertise to Europe’s leading congress on urological cancers. EMUC26 will take place on November 5-8, 2026, in Brussels, Belgium.

The Frontiers Research Foundation endorsed a landmark international Declaration of Intent to expedite data sharing for One Health, reinforcing its commitment to open science and interoperable, AI-ready open data management.

A new research study published in the Journal of the American College of Radiology found that unlike other modalities, linens and disposable supplies account for most of ultrasound’s annual emissions – not equipment energy use.

A routine blood test taken by millions in the U.S. each year to measure “bad” cholesterol is not the best measure to guide treatment and prevent heart attacks and strokes, suggests a new Northwestern Medicine study that published today (April 8) in JAMA.

About The Study: In this cohort study, earlier age at attention-deficit/hyperactivity disorder (ADHD) diagnosis was associated with better school performance, more academic education, and lower school dropout rates than diagnoses closer to age 16. The findings suggest that individuals who are diagnosed closer to age 16 could benefit from targeted support to prevent school dropout. 

About The Study: From 2015 to 2023, the number of U.S. patients who were prescribed long-term opioid therapy declined, potentially owing to national opioid stewardship efforts and growing awareness of the risks. However, approximately 4 million to 5 million patients were prescribed long-term opioid therapy in 2023, depending on the definition used. Moreover, there were demographic shifts in the patients prescribed long-term opioid therapy over this period in that patients were older and the largest proportion now had opioid therapy covered by Medicare. Because older adults are at higher risk of adverse events from polypharmacy, the increased rates of coprescribing, particularly with gabapentinoids, raises additional safety concerns.